Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Value Type description Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1800 to 1849 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b delta subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q9ui10]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5424.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5781.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06587\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5881.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6268.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06584\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1802\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymidylate synthase (ec 2.1.1.45) (ts) (tsase). [source:swissprot;acc:p04818]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4980.54\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5307.81\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06571\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1803\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2 precursor (sdf-2). [source:swissprot;acc:q99470]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1805\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
stromal cell-derived factor 2-like protein 1 precursor (sdf2 like protein 1) (pwp1-interacting protein 8). [source:swissprot;acc:q9hcn8]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1806\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate kinase, m1 isozyme (ec 2.7.1.40) (pyruvate kinase muscle isozyme) (cytosolic thyroid hormone-binding protein) (cthbp) (thbp1). [source:swissprot;acc:p14618]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4783.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5097.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06568\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1807\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
endothelial-derived gene 1. [source:refseq;acc:nm\_025205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6399.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6818.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1808\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysyl-trna synthetase (ec 6.1.1.6) (lysine--trna ligase) (lysrs). [source:swissprot;acc:q15046]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4941.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5265.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06539\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1809\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 3. [source:refseq;acc:nm\_017957]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5816.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6196.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1810\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
colorectal mutant cancer protein (mcc protein). [source:swissprot;acc:p23508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6520.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6946.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06532\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1811\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7659.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8156.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1812\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hrd1 protein isoform a; synoviolin1. [source:refseq;acc:nm\_032431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5514.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5871.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06482\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5866.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06464\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-beta (hsp 84) (hsp 90). [source:swissprot;acc:p08238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5733.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06463\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6104.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6498.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\multirow{17}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shc transforming protein. [source:swissprot;acc:p29353]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 289, id1 regulated; likely ortholog of mouse zfp289. [source:refseq;acc:nm\_032389]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal shc. [source:refseq;acc:nm\_016848]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 1. [source:swissprot;acc:p32889]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a1 (helix-destabilizing protein) (single-strand binding protein) (hnrnp core protein a1). [source:swissprot;acc:p09651]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 3. [source:swissprot;acc:p16587]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1828\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoproteins a2/b1 (hnrnp a2 / hnrnp b1). [source:swissprot;acc:p22626]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1829\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ovarian carcinoma immunoreactive antigen. [source:refseq;acc:nm\_017830]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1830\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase-activating protein 3 (arf gap 3). [source:swissprot;acc:q9np61]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1831\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 2 (sodium-dependent vitamin c transporter 2) (hsvct2) (na(+)/l-ascorbic acid transporter 2) (yolk sac permease-like molecule 2) (nucleobase transporter-like 1 protein). [source:swissprot;acc:q9ugh3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1832\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 7 (ec 2.7.1.-) (map kinase kinase 7) (mapkk 7) (mapk/erk kinase 7) (jnk activating kinase 2) (c-jun n-terminal kinase kinase 2) (jnk kinase 2) (jnkk 2). [source:swissprot;acc:o14733]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-formyltetrahydrofolate cyclo-ligase (ec 6.3.3.2) (5,10-methenyl- tetrahydrofolate synthetase) (methenyl-thf synthetase) (mthfs). [source:swissprot;acc:p49914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6175.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6572.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3593.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3375.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 2 (transcription elongation factor s-ii protein 2) (testis-specific s-ii) (transcription elongation factor tfiis.l). [source:swissprot;acc:q15560]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5019.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5342.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06436\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o). [source:swissprot;acc:p23193]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5739.49\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6108.72\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06433\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1838\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 70 kda subunit (lupus ku autoantigen protein p70) (ku70) (70 kda subunit of ku antigen) (thyroid-lupus autoantigen) (tlaa) (ctc box binding factor 75 kda subunit) (ctcbf) (ctc75). [source:swissprot;acc:p12956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 80 kda subunit (lupus ku autoantigen protein p86) (ku86) (ku80) (86 kda subunit of ku antigen) (thyroid- lupus autoantigen) (tlaa) (ctc box binding factor 85 kda subunit) (ctcbf) (ctc85) (nuclear factor iv) (dna-repair protein xrcc5). [source:swissprot;acc:p13010]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3591.95\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3375.34\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06417\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ligatin (hepatocellular carcinoma-associated antigen 56). [source:swissprot;acc:p41214]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6215.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6613.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-alpha (hsp 86). [source:swissprot;acc:p07900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5746.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6113.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6267.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6668.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06394\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/